Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-549 | GDC-0980 | 2 | 72 | 0.01 | 4451.8 | 4792.0 | 1249.6 | -2.0 | 0.925 | 0.929 | 1.939 | BT549 GDC0980 0 2 72 |
BT-549 | GDC-0980 | 2 | 72 | 0.032 | 4257.3 | 4792.0 | 1249.6 | -1.49 | 0.882 | 0.888 | 1.939 | BT549 GDC0980 0 2 72 |
BT-549 | GDC-0980 | 2 | 72 | 0.1 | 3362.3 | 4792.0 | 1249.6 | -1.0 | 0.666 | 0.702 | 1.939 | BT549 GDC0980 0 2 72 |
BT-549 | GDC-0980 | 2 | 72 | 0.32 | 2205.5 | 4792.0 | 1249.6 | -0.495 | 0.340 | 0.460 | 1.939 | BT549 GDC0980 0 2 72 |
BT-549 | GDC-0980 | 2 | 72 | 1.0 | 1709.5 | 4792.0 | 1249.6 | 0.0 | 0.175 | 0.357 | 1.939 | BT549 GDC0980 0 2 72 |
BT-549 | GDC-0980 | 2 | 72 | 3.2 | 1314.3 | 4792.0 | 1249.6 | 0.505 | 0.026 | 0.274 | 1.939 | BT549 GDC0980 0 2 72 |
BT-549 | Omipalisib | 2 | 72 | 0.001 | 3670.5 | 4963.8 | 1249.6 | -3.0 | 0.719 | 0.739 | 1.990 | BT549 GSK458 0 2 72 |
BT-549 | Omipalisib | 2 | 72 | 0.0032 | 4043.5 | 4963.8 | 1249.6 | -2.49 | 0.804 | 0.815 | 1.990 | BT549 GSK458 0 2 72 |
BT-549 | Omipalisib | 2 | 72 | 0.01 | 2795.3 | 4963.8 | 1249.6 | -2.0 | 0.499 | 0.563 | 1.990 | BT549 GSK458 0 2 72 |
BT-549 | Omipalisib | 2 | 72 | 0.032 | 1971.5 | 4963.8 | 1249.6 | -1.49 | 0.258 | 0.397 | 1.990 | BT549 GSK458 0 2 72 |
BT-549 | Omipalisib | 2 | 72 | 0.1 | 1429.3 | 4963.8 | 1249.6 | -1.0 | 0.070 | 0.288 | 1.990 | BT549 GSK458 0 2 72 |
BT-549 | Omipalisib | 2 | 72 | 0.32 | 1214.0 | 4963.8 | 1249.6 | -0.495 | -0.014 | 0.245 | 1.990 | BT549 GSK458 0 2 72 |
BT-549 | Omipalisib | 2 | 72 | 1.0 | 1045.3 | 4963.8 | 1249.6 | 0.0 | -0.086 | 0.211 | 1.990 | BT549 GSK458 0 2 72 |
BT-549 | Omipalisib | 2 | 72 | 3.2 | 630.0 | 4963.8 | 1249.6 | 0.505 | -0.291 | 0.127 | 1.990 | BT549 GSK458 0 2 72 |
BT-549 | KIN001-244 | 2 | 72 | 0.001 | 4702.8 | 4727.5 | 1249.6 | -3.0 | 0.995 | 0.995 | 1.920 | BT549 KIN001-244 0 2 72 |
BT-549 | KIN001-244 | 2 | 72 | 0.0032 | 4779.8 | 4727.5 | 1249.6 | -2.49 | 1.010 | 1.010 | 1.920 | BT549 KIN001-244 0 2 72 |
BT-549 | KIN001-244 | 2 | 72 | 0.01 | 4625.5 | 4727.5 | 1249.6 | -2.0 | 0.977 | 0.978 | 1.920 | BT549 KIN001-244 0 2 72 |
BT-549 | KIN001-244 | 2 | 72 | 0.032 | 4914.8 | 4727.5 | 1249.6 | -1.49 | 1.040 | 1.040 | 1.920 | BT549 KIN001-244 0 2 72 |
BT-549 | KIN001-244 | 2 | 72 | 0.1 | 4945.8 | 4727.5 | 1249.6 | -1.0 | 1.050 | 1.050 | 1.920 | BT549 KIN001-244 0 2 72 |
BT-549 | KIN001-244 | 2 | 72 | 0.32 | 4618.5 | 4727.5 | 1249.6 | -0.495 | 0.976 | 0.977 | 1.920 | BT549 KIN001-244 0 2 72 |
BT-549 | KIN001-244 | 2 | 72 | 1.0 | 4590.5 | 4727.5 | 1249.6 | 0.0 | 0.970 | 0.971 | 1.920 | BT549 KIN001-244 0 2 72 |
BT-549 | KIN001-244 | 2 | 72 | 3.2 | 4208.3 | 4727.5 | 1249.6 | 0.505 | 0.882 | 0.890 | 1.920 | BT549 KIN001-244 0 2 72 |
BT-549 | MK2206 | 2 | 72 | 0.001 | 4711.0 | 4569.8 | 1249.6 | -3.0 | 1.030 | 1.030 | 1.871 | BT549 MK2206 0 2 72 |
BT-549 | MK2206 | 2 | 72 | 0.0032 | 4598.0 | 4569.8 | 1249.6 | -2.49 | 1.010 | 1.010 | 1.871 | BT549 MK2206 0 2 72 |
BT-549 | MK2206 | 2 | 72 | 0.01 | 4751.3 | 4569.8 | 1249.6 | -2.0 | 1.040 | 1.040 | 1.871 | BT549 MK2206 0 2 72 |